"Vaccine Boom; Evans to Lift Production of Fluvirin"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

April 25, 2003

 

INTERNATIONAL IMMUNIZATION NEWS

 

"Vaccine Boom; Evans to Lift Production of Fluvirin"

Liverpool Daily Post (icliverpool.icnetwork.co.uk) (04/24/03) P. 16; McDonough, Tony

 

Evans Vaccines, the U.K. vaccines maker, is planning to ramp up production of the Fluvirin influenza vaccine.  The move by the subsidiary of PowderJect Pharmaceuticals was prompted by Wyeth withdrawing from the flu vaccine market.  Evans CEO Paul Drayson says another two years to three years will be needed to meet the U.S. demand of 150 million doses of vaccine annually.  He adds that a merger or acquisition could be completed in the near future to boost the company's production capabilities.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.